Published On: Fri, Oct 16th, 2020
World | By

Remdesivir has little effect on hospital stay or mortality in COVID-19 patients, WHO study finds

Remdesivir Gilead

Gilead Sciences Inc.’s remdesivir had little or no effect on COVID-19 patients’ length of hospital stay or chances of survival, a clinical trial by the World Health Organization has found.

CBC | World News